Awarded
Bekanntmachung vergebener Aufträge nach § 130 c SGB V zu dem Arzneimittel Metformin / Dapagliflozin (Xigduo)
- Contract value
- €1
- Bids received
- 1
- Published
- 24 Feb 2026
- Contract start
- 1 Mar 2026
- Contract end
- 31 Mar 2028stated
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|
| Valganciclovir (FTA) | GWQ ServicePlus AG | Amarox Pharma GmbH, PUREN Pharma GmbH & Co. KG, Viatris Healthcare GmbH, Zweigniederlassung Bad Homburg | — | 11 Aug 2026 |
| Ticagrelor (FTA) | GWQ ServicePlus AG | 089Pharm GmbH, Ascend GmbH, Zentiva Pharma GmbH | — | 11 Aug 2026 |
| Temozolomid (HKP) | GWQ ServicePlus AG | Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH, Fairmed Healthcare GmbH, medac GmbH | — | 11 Aug 2026 |
| Telmisartan + HCT (TAB, FTA) | GWQ ServicePlus AG | BG Heumann / Heunet GbR, Micro Labs GmbH, Zentiva Pharma GmbH | — | 11 Aug 2026 |
| Telmisartan (TAB, FTA) | GWQ ServicePlus AG | Medical Valley Invest AB, Micro Labs GmbH, Zentiva Pharma GmbH | — | 11 Aug 2026 |
| Tapentadol (RET) | GWQ ServicePlus AG | BG ALIUD / STADAPHARM GbR, G.L. Pharma Deutschland GmbH, Micro Labs GmbH | — | 11 Aug 2026 |